![Nurix Therapeutics Inc](/common/images/company/N_NRIX.png)
Nurix Therapeutics Inc (NRIX)
NASDAQ
Fin d'année 30 Novembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -41.536 | -48.519 | -19.638 | -26.845 | -40.37 | -37.275 | -37.772 |
Return on Equity (%) | 51.174 | 45.894 | -37.189 | -37.053 | -55.839 | -57.101 | -53.216 |
Return on Invested Capital (%) | -185.835 | -6562.044 | -47.112 | -58.858 | -84.171 | -73.274 | -59.975 |
Operating Margin (%) | -23.822 | -68.97 | -357.896 | -393.489 | -466.927 | -186.977 | -354.358 |
Net Profit Margin (%) | -25.176 | -69.738 | -242.66 | -393.929 | -466.927 | -186.977 | -354.853 |
Book Value Per Share | 1.096 | -0.883 | 7.469 | 7.664 | 6.438 | 4.134 | 7.44 |
Earnings Per Share | -0.91 | -2.012 | -1.113 | -2.624 | -3.823 | -2.968 | -2.733 |
Cash Per Share | 2.471 | 3.228 | 3.071 | 1.802 | 1.367 | 1.126 | 1.553 |
Working Capital Per Share | 0.755 | 2.153 | 6.533 | 5.482 | 5.253 | 4.3 | 7.391 |
Operating Profit Per Share | 3.615 | 2.885 | 0.459 | 0.666 | 0.819 | 1.587 | 0.77 |
EBIT Per Share | -0.861 | -1.99 | -1.641 | -2.621 | -3.823 | -2.968 | -2.729 |
EBITDA Per Share | -0.861 | -1.99 | -1.641 | -2.621 | -3.823 | -2.968 | -2.729 |
Free Cash Flow Per Share | -1.045 | -2.077 | -1.052 | -2.56 | -3.677 | -2.95 | -2.733 |
Fin d'année 30 Novembre 2024 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 10,36M | 10,79M | 38,87M | 44,66M | 47,17M | N/A | N/A |
Fin d'année 30 Novembre 2024 | Fév 2023 | Mai 2023 | Août 2023 | Nov 2023 | Fév 2024 | Mai 2024 | Août 2024 | Nov 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | N/A | 48,2M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -321.112 | N/A | N/A | N/A | -249.792 | N/A | N/A | N/A |
Net Profit Margin (%) | -321.112 | N/A | N/A | N/A | -250.335 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,27B |
Ratio cours/bénéfice | -6,56 |
Ratio prix/ventes | 23,27 |
Ratio prix/liquidités | 11,54 |
Ratio prix/valeur comptable | 2,41 |
Rendement de dividende | - |
Actions en circulation | 75,89M |
Volume moyen (1 semaine) | 578,23k |
Volume moyen (1 mois) | 638,05k |
Variation sur 52 semaines | 75,74% |
Plus haut sur 52 semaines | 29,56 |
Plus bas sur 52 semaines | 9,52 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales